112: MSIF – Past, Present and Future with Peer Baneke and Lydia Makaroff

112: MSIF – Past, Present and Future with Peer Baneke and Lydia Makaroff

Learn how MSIF is shaping a better future for people with MS—through global collaboration, advocacy, and the power of lived experience.

Read the interview highlights on my blog: https://ms-perspektive.com/112-msif

The Multiple Sclerosis International Federation (MSIF) plays a vital role in uniting the global MS community to improve the lives of people affected by multiple sclerosis. In this inspiring interview, Peer Baneke, former CEO, and Lydia Makaroff, the new CEO, share their insights on past milestones, current challenges, and the future vision of MSIF. From global access to treatments, early diagnosis, and mental health support to patient-led research and digital innovation—this conversation offers valuable perspectives for anyone living with MS or working to support those who do.

👉 Take a moment to listen to the full podcast episode or read the interview highlights—whether you're living with MS, supporting a loved one, or working in the field, there's something here for you. Let's stay connected, informed, and inspired—together with the global MS community. 💪🧡

Introduction & Personal Insights Peer, you recently retired after many years at MSIF. Could you briefly introduce yourself and share a personal hobby that kept you grounded during your time as CEO?

Peer Baneke: I'm Peer Baneke, and I served as CEO of MSIF for 18 years. Before that, I worked in human rights and refugee support. MS is close to my heart—my father had MS—and I've lived in and around London for over 40 years. What keeps me grounded is my family and cycling. Now that I'm retired, I enjoy even more time for it.

Lydia, congratulations on your new role! Can you tell us a bit about your background and what motivates you to lead MSIF?

Lydia Makaroff: Thank you! I grew up in Australia and worked in the US, Belgium, and now here. I've always believed in international collaboration. My background spans science, the pharmaceutical industry, and civil society. What drives me is the opportunity MSIF has to truly create global change for people affected by MS.

Peer, what message of hope would you like to share?

Peer Baneke: There will be progress. Despite global challenges, research and advocacy are moving forward. The commitment of the MS community gives me great hope for the future.

Lydia, where can listeners learn more about MSIF?

Lydia Makaroff: Visit www.msif.org, and follow us on Instagram or LinkedIn. Also, check out www.worldmsday.org and join our MS Heart Challenge on May 30th.

---

Thank you for the incredible achievements so far, and for all the important work MSIF is doing and will continue to do in the future.

See you soon and try to make the best out of your life,
Nele

For more information and positive thoughts, subscribe to my newsletter for free.

Click here for an overview of all podcast episodes published so far.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(193)

#191: BTK inhibitors in MS: where do we stand after ECTRIMS/ACTRIMS 2026?

#191: BTK inhibitors in MS: where do we stand after ECTRIMS/ACTRIMS 2026?

BTK inhibitors have produced different results in multiple sclerosis trials. In episode no. 191, I explore what we learned at ECTRIMS/ACTRIMS 2026 about individual medicines, their potential benefits ...

11 Nov 19min

#190: Living with multiple sclerosis. Gabriela's story and the "(un)seen faces of MS" Art Project

#190: Living with multiple sclerosis. Gabriela's story and the "(un)seen faces of MS" Art Project

https://ms-perspektive.de/en/190-unseen-faces-of-ms/Living with multiple sclerosis often means experiencing symptoms that others cannot see. Austrian artist Gabriela Romagna shares her journey to an M...

4 Nov 32min

#189: New imaging in MS: understanding progression and finding better treatments | ECTRIMS 2026

#189: New imaging in MS: understanding progression and finding better treatments | ECTRIMS 2026

How could new imaging in MS help us understand progression and develop better treatments? In this episode, I explore key insights from Daniel Reich's MSToronto2026 lecture and related research. Learn ...

28 Okt 15min

#188: Jan Van Amstel on EMSP's Four-Year Presidency and the Future of MS Advocacy in Europe

#188: Jan Van Amstel on EMSP's Four-Year Presidency and the Future of MS Advocacy in Europe

"Get rid of MS as soon as possible and make ourselves superfluous." — Jan van Amstel What can a stronger European voice achieve for people living with MS? In episode #188, EMSP President Jan van Amste...

21 Okt 31min

#187: Aging in multiple sclerosis: relapses, progression and treatment choices with Dr. Yi Chao Foong

#187: Aging in multiple sclerosis: relapses, progression and treatment choices with Dr. Yi Chao Foong

Aging in multiple sclerosis brings new questions about relapses, gradual progression and treatment choices. In episode 187, Dr. Yi Chao Foong, an MS neurologist and researcher in Tasmania, explains wh...

14 Okt 29min

#186: Protecting nerve cells in multiple sclerosis: A new path toward neuroprotection with Prof. Manuel Friese

#186: Protecting nerve cells in multiple sclerosis: A new path toward neuroprotection with Prof. Manuel Friese

Why can multiple sclerosis progress even when relapses are well controlled? In episode 186, I speak with Prof. Manuel Friese about the next challenge in MS research: protecting nerve cells from damage...

7 Okt 43min

#185: Living with MS in Mexico – who gets diagnosed, who gets treated, and who gets left behind?

#185: Living with MS in Mexico – who gets diagnosed, who gets treated, and who gets left behind?

An MS diagnosis can depend on where you live, whether you can reach a neurologist and how quickly you can get an MRI. In this episode, Nele speaks with neurologist and neuroimmunologist Dr. Enrique Go...

30 Sep 36min

#184: MS treatment across the disease course – treat early, think long-term, don't give up too soon with Prof. Klaus Schmierer

#184: MS treatment across the disease course – treat early, think long-term, don't give up too soon with Prof. Klaus Schmierer

Read the full blog post and interview here: https://ms-perspektive.de/en/184-klaus-schmierer/ How early should MS treatment start, how strongly should we treat, and is there ever a point when it becom...

23 Sep 41min

Populært innen Fakta

fastlegen
dine-penger-pengeradet
fryktlos
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
rss-strid
foreldreradet
treningspodden
rss-bisarr-historie
rss-ekteskapet
jakt-og-fiskepodden
rss-kunsten-a-leve
rss-kull
mikkels-paskenotter
rss-orjasater
sinnsyn
gravid-uke-for-uke
rss-flydilla
rss-mind-body-podden
hverdagspsyken
branncast